Annals of Clinical Biochemistry > Volume 46, Number 3 > Pp. 231-234

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: acb.2009.008207v1 46/3/231    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bakker, D J. Articles by Fokkema, M R. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original Articles

Controlled study on folate status following folic acid supplementation and discontinuation in women of child-bearing age

D Joyce Bakker¹, Lolkje T W de Jong-van den Berg² and M Rebecca Fokkema¹

¹ Department of Pathology and Laboratory Medicine, University Medical Center Groningen; ² Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Department of Pharmacy, University of Groningen, Groningen, The Netherlands

Corresponding author: Dr M R Fokkema, Department of Laboratory Medicine, University Medical Centre Groningen, CMC-IV, Room Y2.119, P.O. Box 30.001, Groningen NL-9700 RB, The Netherlands. Email: m.r.heiner{at}lc.umcg.nl

Background: To decrease the incidence of neural tube defects, active efforts are currently undertaken to promote folic acid (FA) intake among women. In 2003, the Food and Drug Administration approved the proposal of introducing an oral contraceptive (OC) and FA combination pill. It is unknown whether these pills will reduce neural tube defect incidence for couples who do not become pregnant soon after discontinuation. We studied FA kinetics up to 12 weeks discontinuation of eight weeks 500 µg/d FA in 27 healthy Dutch women of child-bearing age.

Methods: In this controlled study, women were assigned to an intervention group (n = 13) or a control group (n = 14). The total study duration was 20 weeks, during which the subjects had to give blood on nine occasions (week –8 [baseline], –4, 0, 1, 2, 3, 4, 8 and 12) for analyses of serum and erythrocyte folate, and plasma total homocysteine. The intervention group received 500 µg/d FA during the first eight weeks, and discontinued the intake from weeks 0 to 12. No supplements were supplied to the control group.

Results: Serum folate and plasma total homocysteine returned to baseline after 12 weeks of FA discontinuation, erythrocyte folate did not.

Conclusion: An FA/OC combination pill seems to be of value for only a minor portion of women. Active efforts to stimulate women of child-bearing age to take FA remain essential.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?